Find Clinical Trials | Cedars-Sinai

31 results found

Anus, Bones and Joints, Brain and Nervous System, Breast, Cervix ...

Targeted Agent and Profiling Utilization Registry (TAPUR) Study

This study focuses on patients who have been diagnosed with an advanced cancer that has not responded to or has stopped responding to at least one kind of treatment, or that has no standard therapy. ...

Melanoma

mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma

The purpose of this study is to examine whether the investigational combination of the drugs pembrolizumab and mRNA-4157 work better than pembrolizumab alone to prevent recurrence in high-risk melanoma. The study will also evaluate the ...

Melanoma, Other Skin, Other Urinary, Ovary, Unknown Sites

IMC-F106C in Advanced Cancers

The purpose of this study is to determine the safety and effectiveness of an investigational immunotherapeutic drug called IMC-F106C in multiple cancers (endometrial, ovarian, melanoma, ocular melanoma, triple-negative breast, lung, and bladder cancer) expressing a ...

Melanoma

Early Discontinuation of Anti-PD-1 Therapy in Patients With Advanced Melanoma

This study focuses on individuals who have advanced melanoma cancer that is currently being treated with one immunotherapy drug (anti-PD-1 drugs nivolumab or pembrolizumab) or a combination of nivolumab and ipilimumab. Researchers aim to determine ...

Breast, Colon, Esophagus, Kidney, Lung, Melanoma, Ovary

Shionogi, 2023P2411(aCCeleR8-001), Ph1b/2,Open,Advanced Solid Tumors,S-531011 +/- Pembrolizumab

Primary: -To evaluate the safety and tolerability of S-531011 and to determine the MTD and/or RP2D of S-531011. Secondary: - To evaluate the preliminary antitumor activity of S-531011 per RECIST version 1.1a. - To characterize the PK profile ...